Dow component Merck reported an adjusted 4Q profit of $0.89 per share, matching expectations. Revenue for the drugmaker came in at $10.1 billion, missing the estimate for $10.2 billion
Continue Reading Below
Our editors found this article on this site using Google and regenerated it for our readers.
